|Day Low/High||18.61 / 19.62|
|52 Wk Low/High||7.56 / 29.09|
An update on the market and my stock of the week, TPI Composites.
Flexion (FLXN) stock closed sharply lower on Wednesday after announcing plans to raise $77 million from a stock offering.
There is some good speculative trading and metals are the place to be.
Investors eyeing a purchase of Flexion Therapeutics, Inc. stock, but tentative about paying the going market price of $15.38/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Study to Determine If Zilretta Can Avoid the Hyperglycemia that is Commonly Observed in Diabetic Patients Who Receive Immediate-Release Triamcinolone Acetonide (TCA) Injections for Knee Osteoarthritis
Podium presentation highlights results from pivotal clinical trials completed in patients with osteoarthritis (OA) of the knee
These stocks trading for less than $10 a share are within range of triggering big breakout trades.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Investors in Flexion Therapeutics, Inc. saw new options begin trading this week, for the April 15th expiration.
Flexion (FLXN) stock is advancing on heavy trading volume on Wednesday after the company said its osteoarthritis treatment met its primary endpoint during a Phase 3 clinical trial.